Stocks and Investing Stocks and Investing
Mon, May 13, 2024

Edward Nash Maintained (AKRO) at Strong Buy with Decreased Target to $56 on, May 13th, 2024


Published on 2024-10-28 11:19:13 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Decreased Target from $59 to $56 on, May 13th, 2024.

Edward has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alexandria Hammond of "B of A Securities" Initiated at Hold and Held Target at $30 on, Monday, April 22nd, 2024


This is the rating of the analyst that currently disagrees with Edward


  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, March 5th, 2024

Contributing Sources